ES2166816T3 - Derivados piridil-imidazolicos y procedimientos para su preparacion. - Google Patents
Derivados piridil-imidazolicos y procedimientos para su preparacion.Info
- Publication number
- ES2166816T3 ES2166816T3 ES95909125T ES95909125T ES2166816T3 ES 2166816 T3 ES2166816 T3 ES 2166816T3 ES 95909125 T ES95909125 T ES 95909125T ES 95909125 T ES95909125 T ES 95909125T ES 2166816 T3 ES2166816 T3 ES 2166816T3
- Authority
- ES
- Spain
- Prior art keywords
- piridil
- procedures
- preparation
- derivatives
- imidazolic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
- WGNUNYPERJMVRM-UHFFFAOYSA-N 3-pyridylacetic acid Chemical class OC(=O)CC1=CC=CN=C1 WGNUNYPERJMVRM-UHFFFAOYSA-N 0.000 abstract 1
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
NUEVOS DERIVADOS SUSTITUIDOS DE PIRIDIL IMIDAZOL DE FORMULA (I) INHIBEN EFICAZMENTE LA ACCION DE LA ANGIOTENSINA II Y TIENEN UNA ACTIVIDAD ANTIHIPERTENSORA SUPERIOR.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19940002354 | 1994-02-08 | ||
| KR19940013795 | 1994-06-18 | ||
| KR19940017900 | 1994-07-25 | ||
| KR1019950001286A KR0151816B1 (ko) | 1994-02-08 | 1995-01-25 | 신규의 치환된 피리딜 이미다졸 유도체 및 그의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2166816T3 true ES2166816T3 (es) | 2002-05-01 |
Family
ID=27483030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95909125T Expired - Lifetime ES2166816T3 (es) | 1994-02-08 | 1995-02-08 | Derivados piridil-imidazolicos y procedimientos para su preparacion. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5849753A (es) |
| EP (1) | EP0743943B1 (es) |
| JP (1) | JP2905599B2 (es) |
| KR (1) | KR0151816B1 (es) |
| AU (1) | AU691879B2 (es) |
| CA (1) | CA2182477C (es) |
| DE (1) | DE69523571T2 (es) |
| ES (1) | ES2166816T3 (es) |
| WO (1) | WO1995021838A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0994877A1 (en) | 1997-07-03 | 2000-04-26 | Du Pont Pharmaceuticals Company | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| US6465484B1 (en) * | 1997-09-26 | 2002-10-15 | Merck & Co., Inc. | Angiogenesis inhibitors |
| US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
| AR051596A1 (es) | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
| ES2274712B1 (es) * | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| KR101117128B1 (ko) * | 2009-06-02 | 2012-03-14 | 한국화학연구원 | 페닐테트라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증 또는 비만의 예방 또는 치료용 약학적 조성물 |
| US8372862B2 (en) | 2009-06-02 | 2013-02-12 | Korea Research Institute Of Chemical Technology | Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative |
| WO2011134019A1 (en) * | 2010-04-30 | 2011-11-03 | The University Of Melbourne | Novel biphenyl sartans |
| CN103781786A (zh) * | 2011-07-15 | 2014-05-07 | 盐野义制药株式会社 | 具有ampk活化作用的氮杂苯并咪唑衍生物 |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64514B1 (en) * | 1989-05-23 | 1995-08-09 | Zeneca Ltd | Azaindenes |
| IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them |
| IE70593B1 (en) * | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
| IL96019A0 (en) * | 1989-10-31 | 1991-07-18 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5053329A (en) * | 1990-07-05 | 1991-10-01 | Merck & Co., Inc. | Process for preparation of novel angiotensin II antagonists |
| US5066586A (en) * | 1990-08-20 | 1991-11-19 | Merck & Co., Inc. | Process for preparation of novel angiotensin II antagonists |
| US5049565A (en) * | 1990-12-07 | 1991-09-17 | Merck & Co., Inc. | Microbial transformation process for preparing anti-hypertensive products |
-
1995
- 1995-01-25 KR KR1019950001286A patent/KR0151816B1/ko not_active Expired - Fee Related
- 1995-02-08 WO PCT/KR1995/000009 patent/WO1995021838A1/en not_active Ceased
- 1995-02-08 DE DE69523571T patent/DE69523571T2/de not_active Expired - Fee Related
- 1995-02-08 CA CA002182477A patent/CA2182477C/en not_active Expired - Fee Related
- 1995-02-08 ES ES95909125T patent/ES2166816T3/es not_active Expired - Lifetime
- 1995-02-08 EP EP95909125A patent/EP0743943B1/en not_active Expired - Lifetime
- 1995-02-08 US US08/682,684 patent/US5849753A/en not_active Expired - Fee Related
- 1995-02-08 AU AU17184/95A patent/AU691879B2/en not_active Ceased
- 1995-02-08 JP JP7521124A patent/JP2905599B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU691879B2 (en) | 1998-05-28 |
| EP0743943B1 (en) | 2001-10-31 |
| JP2905599B2 (ja) | 1999-06-14 |
| KR0151816B1 (ko) | 1998-10-15 |
| CA2182477C (en) | 1999-06-15 |
| CA2182477A1 (en) | 1995-08-17 |
| KR950025039A (ko) | 1995-09-15 |
| WO1995021838A1 (en) | 1995-08-17 |
| US5849753A (en) | 1998-12-15 |
| EP0743943A1 (en) | 1996-11-27 |
| JPH09507675A (ja) | 1997-08-05 |
| DE69523571T2 (de) | 2002-07-25 |
| DE69523571D1 (de) | 2001-12-06 |
| AU1718495A (en) | 1995-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| FI973452L (fi) | Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen | |
| FI971776A7 (fi) | Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi | |
| DE69526237D1 (de) | Chirurgische gesichtsmaske | |
| ATE300597T1 (de) | Behandlung von geweben | |
| ITMI942365A0 (it) | Retina per la chirurgia ortopedica-traumatologica | |
| FI952033A7 (fi) | Farmakologisesti aktiiviset pyrrolopyrimidiinijohdannaiset | |
| FI971412L (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
| AR009356A1 (es) | Compuesto de 1-4 heterociclico, inhibidor de la metaloproteasa y su uso para preparar una composicion farmaceutica y para prevenir o tratar una enfermedad asociada con la actividad de la metalo proteasa y la caquexia | |
| YU49315B (sh) | Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje | |
| BR9504535A (pt) | Escalpelo cirúrgico protegido | |
| BR9503362A (pt) | Escaopelo cirúrgico protegido | |
| FI932695A7 (fi) | Angiotensiini I kymaasi(e)n inhibiittoreita, mukaanlukien ihmisen sydänkymaasin | |
| LV12232A (lv) | Zinami fosfinilatvasinajumi ka naaldazes inhibitori | |
| BG102616A (en) | Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application | |
| SE9900961D0 (sv) | Novel compounds | |
| DE69729817D1 (de) | Behandlung von Aldehyd-fixierten Geweben | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| SE9802208D0 (sv) | Novel compounds | |
| ES2166816T3 (es) | Derivados piridil-imidazolicos y procedimientos para su preparacion. | |
| ES2221950T3 (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios. | |
| BR9706908A (pt) | Composiçães para o tratamento de insuficiéncia renal compreendendo l-carnosina | |
| ATE234359T1 (de) | Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia | |
| ID29966A (id) | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi |